Wolfe Research Downgrades Janux Therapeutics to Peer Perform
Janux Therapeutics, Inc. (JANX) Discusses JANX011 Phase 1 Healthy Volunteer Data and Autoimmune Development Strategy - Slideshow
Janux Therapeutics Stock In Focus As Loss Narrows And Phase 1 Data Nears
Janux Therapeutics, Inc. (JANX) Discusses JANX011 Phase 1 Healthy Volunteer Data and Autoimmune Development Strategy Transcript
Janux Reports Deep B-Cell Depletion in Initial Phase 1 Trial of JANX011; Shares Fall
Janux Therapeutics Announces Positive Initial Phase 1 Data for JANX011 in Healthy Volunteers, Supporting Planned Development in Patients with Autoimmune Disease
Janux Therapeutics Reports Initial Phase 1 JANX011 Data, Providing Clinical Validation For ARM Platform In Autoimmune Diseases
Janux Therapeutics (JANX) Earnings Beat Brings Its Pricey Valuation Back Into Focus
Truist Securities Maintains Buy on Janux Therapeutics, Raises Price Target to $27
Wedbush Maintains Outperform on Janux Therapeutics, Raises Price Target to $40
Barclays Maintains Underweight on Janux Therapeutics, Raises Price Target to $15
Janux Therapeutics, Inc. (JANX) Reports Q3 Loss, Beats Revenue Estimates
Janux Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights
Janux Therapeutics Q3 EPS $(0.34) Beats $(0.46) Estimate, Sales $9.290M Beat $7.746M Estimate
Janux Therapeutics to Host Virtual Event Presenting Initial Phase 1 Clinical Data for JANX011 in Healthy Volunteers
Janux Therapeutics (JANX) Stock Looks Above Fair Value Based On Sales
Janux Therapeutics (JANX), What Is Drawing Fresh Attention Now?
Janux Therapeutics (JANX) Stock May Look Overvalued After Its 110% Run
Is Janux’s Dual JANX013–JANX007 Trial Advancing a Durable Precision Oncology Platform for JANX?
Janux Therapeutics (JANX) Advances Prostate Cancer Trial While Valuation Still Looks Pricey
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.